HEADER HISTOCOMPATIBILITY ANTIGEN I-AK 18-NOV-97 1IAK TITLE HISTOCOMPATIBILITY ANTIGEN I-AK COMPND MOL_ID: 1; COMPND 2 MOLECULE: MHC CLASS II I-AK; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: WITH COVALENTLY BOUND HEL PEPTIDE; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: MHC CLASS II I-AK; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: WITH COVALENTLY BOUND HEL PEPTIDE; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: MHC CLASS II I-AK; COMPND 13 CHAIN: P; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: WITH COVALENTLY BOUND HEL PEPTIDE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELL_LINE: CHO; SOURCE 6 ORGAN: EGG; SOURCE 7 EXPRESSION_SYSTEM: CHO CELLS AS GPI-LINKED PROTEIN; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 CELL_LINE: CHO; SOURCE 13 ORGAN: EGG; SOURCE 14 EXPRESSION_SYSTEM: CHO CELLS AS GPI-LINKED PROTEIN; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 17 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 18 ORGANISM_TAXID: 10090; SOURCE 19 EXPRESSION_SYSTEM: CHO CELLS AS GPI-LINKED PROTEIN KEYWDS HISTOCOMPATIBILITY ANTIGEN, MHC, PEPTIDE COMPLEX, HISTOCOMPATIBILITY KEYWDS 2 ANTIGEN I-AK EXPDTA X-RAY DIFFRACTION AUTHOR D.H.FREMONT,E.R.UNANUE,W.A.HENDRICKSON REVDAT 6 09-AUG-23 1IAK 1 HETSYN REVDAT 5 29-JUL-20 1IAK 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 16-NOV-11 1IAK 1 HETATM REVDAT 3 13-JUL-11 1IAK 1 VERSN REVDAT 2 24-FEB-09 1IAK 1 VERSN REVDAT 1 15-APR-98 1IAK 0 JRNL AUTH D.H.FREMONT,D.MONNAIE,C.A.NELSON,W.A.HENDRICKSON,E.R.UNANUE JRNL TITL CRYSTAL STRUCTURE OF I-AK IN COMPLEX WITH A DOMINANT EPITOPE JRNL TITL 2 OF LYSOZYME. JRNL REF IMMUNITY V. 8 305 1998 JRNL REFN ISSN 1074-7613 JRNL PMID 9529148 JRNL DOI 10.1016/S1074-7613(00)80536-1 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0100 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 47865 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2410 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.99 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5627 REMARK 3 BIN R VALUE (WORKING SET) : 0.3570 REMARK 3 BIN FREE R VALUE : 0.3920 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 293 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3129 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 369 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.22000 REMARK 3 B22 (A**2) : -4.22000 REMARK 3 B33 (A**2) : 8.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.34 REMARK 3 LOW RESOLUTION CUTOFF (A) : 10.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.32 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.180 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.470 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.530 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.650 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.670 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM3_MOD.CHO REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH3.CHO REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IAK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174089. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 4.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : FUJI REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, AGROVATA, HKL REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (AGROVATA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48139 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 4.120 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.27000 REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1IEA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000, 7% EG, 80MM A.S, 200MM REMARK 280 AMM.ACETATE, 50MM NA.ACETATE PH 4.75 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.86000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 56.12500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 56.12500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 24.93000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 56.12500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 56.12500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 74.79000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 56.12500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.12500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 24.93000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 56.12500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 56.12500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 74.79000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 49.86000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 191 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 THIS ENTRY CONTAINS COORDINATES FOR THE EXTRACELLULAR REMARK 400 DOMAINS OF THE MURINE MHC CLASS II MOLECULE I-AK WITH A. REMARK 400 PEPTIDE FROM HEN EGG WHITE LYSOZYME (50 - 62) COVALENTLY REMARK 400 ATTACHED TO THE I-AK BETA CHAIN VIA A POLYPEPTIDE LINKER. REMARK 400 THE HETERODIMER WAS EXPRESSED IN CHO CELLS AS A GPI-LINKED REMARK 400 PROTEIN AND ENZYMATICALLY CLEAVED WITH PIPLC. FOR THE I-AK REMARK 400 ALPHA CHAIN, THE FIRST 3 RESIDUES AND LAST 14 RESIDUES REMARK 400 COULD NOT BE TRACED. FOR THE BETA CHAIN, 10 RESIDUES AMINO REMARK 400 TERMINAL TO THE HEL PEPTIDE AND 16 RESIDUES IN THE COVALENT REMARK 400 LINKER WERE DISORDERED, AS WERE 15 RESIDUES AT THE REMARK 400 C-TERMINAL TAIL OF THE BETA CHAIN. THE FIRST TWO RESIDUES REMARK 400 BUILT IN THE BETA CHAIN (GLY B5 AND SER B6) ARE IN FACT REMARK 400 CLONING ARTIFACTS OF THE LINKER CONSTRUCTION, AS THESE REMARK 400 RESIDUES ARE ARG B5 AND HIS B6 IN THE NATURAL I-AK REMARK 400 SEQUENCE. REMARK 400 REMARK 400 THE HETEROATOM WATER 1 SITS AT A SPECIAL POSITION. ALL REMARK 400 OTHER WATERS ARE NUMBERED IN ORDER OF THEIR TEMPERATURE REMARK 400 FACTOR. REMARK 400 REMARK 400 HEL PEPTIDE RESIDUES 50-62 CORRESPOND TO BINDING SITES P-2 REMARK 400 TO P11. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A -2 REMARK 465 ASP A -1 REMARK 465 ASP A 0 REMARK 465 ILE A 182 REMARK 465 PRO A 183 REMARK 465 ALA A 184 REMARK 465 PRO A 185 REMARK 465 MET A 186 REMARK 465 SER A 187 REMARK 465 GLU A 188 REMARK 465 LEU A 189 REMARK 465 THR A 190 REMARK 465 GLU A 191 REMARK 465 THR A 192 REMARK 465 VAL A 193 REMARK 465 VAL A 194 REMARK 465 CYS A 195 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 39 60.13 61.22 REMARK 500 ASN A 78 53.10 70.98 REMARK 500 PHE A 113 123.54 -173.81 REMARK 500 PRO A 115 56.61 -68.61 REMARK 500 SER A 125 16.68 59.39 REMARK 500 PRO A 180 -180.00 -63.32 REMARK 500 ASN B 33 -96.46 59.99 REMARK 500 THR B 89 -86.48 -130.86 REMARK 500 ALA B 108 104.35 -170.83 REMARK 500 THR B 139 -67.75 -130.35 REMARK 500 TRP B 153 31.47 75.38 REMARK 500 REMARK 500 REMARK: NULL DBREF 1IAK A -2 195 UNP P01910 HA2K_MOUSE 24 222 DBREF 1IAK B 5 190 UNP P06343 HB2K_MOUSE 28 216 DBREF 1IAK P 50 62 UNP P24364 LYC_LOPLE 50 62 SEQADV 1IAK GLY B 5 UNP P06343 ASN 29 CONFLICT SEQADV 1IAK B UNP P06343 GLU 31 DELETION SEQADV 1IAK B UNP P06343 ARG 32 DELETION SEQADV 1IAK B UNP P06343 HIS 33 DELETION SEQADV 1IAK THR B 181 UNP P06343 LYS 207 CONFLICT SEQRES 1 A 199 GLU ASP ASP ILE GLU ALA ASP HIS VAL GLY SER TYR GLY SEQRES 2 A 199 ILE THR VAL TYR GLN SER PRO GLY ASP ILE GLY GLN TYR SEQRES 3 A 199 THR PHE GLU PHE ASP GLY ASP GLU LEU PHE TYR VAL ASP SEQRES 4 A 199 LEU ASP LYS LYS GLU THR VAL TRP MET LEU PRO GLU PHE SEQRES 5 A 199 ALA GLN LEU ARG ARG PHE GLU PRO GLN GLY GLY LEU GLN SEQRES 6 A 199 ASN ILE ALA THR GLY LYS HIS ASN LEU GLU ILE LEU THR SEQRES 7 A 199 LYS ARG SER ASN SER THR PRO ALA THR ASN GLU ALA PRO SEQRES 8 A 199 GLN ALA THR VAL PHE PRO LYS SER PRO VAL LEU LEU GLY SEQRES 9 A 199 GLN PRO ASN THR LEU ILE CYS PHE VAL ASP ASN ILE PHE SEQRES 10 A 199 PRO PRO VAL ILE ASN ILE THR TRP LEU ARG ASN SER LYS SEQRES 11 A 199 SER VAL THR ASP GLY VAL TYR GLU THR SER PHE PHE VAL SEQRES 12 A 199 ASN ARG ASP TYR SER PHE HIS LYS LEU SER TYR LEU THR SEQRES 13 A 199 PHE ILE PRO SER ASP ASP ASP ILE TYR ASP CYS LYS VAL SEQRES 14 A 199 GLU HIS TRP GLY LEU GLU GLU PRO VAL LEU LYS HIS TRP SEQRES 15 A 199 GLU PRO GLU ILE PRO ALA PRO MET SER GLU LEU THR GLU SEQRES 16 A 199 THR VAL VAL CYS SEQRES 1 B 185 GLY SER PHE VAL HIS GLN PHE GLN PRO PHE CYS TYR PHE SEQRES 2 B 185 THR ASN GLY THR GLN ARG ILE ARG LEU VAL ILE ARG TYR SEQRES 3 B 185 ILE TYR ASN ARG GLU GLU TYR VAL ARG PHE ASP SER ASP SEQRES 4 B 185 VAL GLY GLU TYR ARG ALA VAL THR GLU LEU GLY ARG PRO SEQRES 5 B 185 ASP ALA GLU TYR TRP ASN LYS GLN TYR LEU GLU ARG THR SEQRES 6 B 185 ARG ALA GLU LEU ASP THR VAL CYS ARG HIS ASN TYR GLU SEQRES 7 B 185 LYS THR GLU THR PRO THR SER LEU ARG ARG LEU GLU GLN SEQRES 8 B 185 PRO SER VAL VAL ILE SER LEU SER ARG THR GLU ALA LEU SEQRES 9 B 185 ASN HIS HIS ASN THR LEU VAL CYS SER VAL THR ASP PHE SEQRES 10 B 185 TYR PRO ALA LYS ILE LYS VAL ARG TRP PHE ARG ASN GLY SEQRES 11 B 185 GLN GLU GLU THR VAL GLY VAL SER SER THR GLN LEU ILE SEQRES 12 B 185 ARG ASN GLY ASP TRP THR PHE GLN VAL LEU VAL MET LEU SEQRES 13 B 185 GLU MET THR PRO ARG ARG GLY GLU VAL TYR THR CYS HIS SEQRES 14 B 185 VAL GLU HIS PRO SER LEU THR SER PRO ILE THR VAL GLU SEQRES 15 B 185 TRP ARG ALA SEQRES 1 P 13 SER THR ASP TYR GLY ILE LEU GLN ILE ASN SER ARG TRP MODRES 1IAK ASN A 78 ASN GLYCOSYLATION SITE MODRES 1IAK ASN A 118 ASN GLYCOSYLATION SITE MODRES 1IAK ASN B 19 ASN GLYCOSYLATION SITE HET NAG A 196 14 HET NAG A 197 14 HET NAG B 3 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG 3(C8 H15 N O6) FORMUL 7 HOH *369(H2 O) HELIX 1 1 PRO A 46 GLN A 50 5 5 HELIX 2 2 PRO A 56 SER A 77 1 22 HELIX 3 3 GLY B 20 GLN B 22 5 3 HELIX 4 4 GLU B 52 GLN B 64 5 13 HELIX 5 5 LEU B 68 THR B 77 1 10 HELIX 6 6 CYS B 79 LYS B 84A 1 7 HELIX 7 7 SER B 90 ARG B 92 5 3 SHEET 1 A 4 GLU A 40 TRP A 43 0 SHEET 2 A 4 ASP A 29 ASP A 35 -1 N ASP A 35 O GLU A 40 SHEET 3 A 4 ILE A 19 PHE A 26 -1 N PHE A 26 O ASP A 29 SHEET 4 A 4 GLY A 7 GLN A 14 -1 N GLN A 14 O ILE A 19 SHEET 1 B 4 GLN A 88 PRO A 93 0 SHEET 2 B 4 PRO A 102 ASP A 110 -1 N ASP A 110 O GLN A 88 SHEET 3 B 4 LYS A 147 ILE A 154 -1 N PHE A 153 O ASN A 103 SHEET 4 B 4 VAL A 132 GLU A 134 -1 N TYR A 133 O TYR A 150 SHEET 1 C 3 ASN A 118 ARG A 123 0 SHEET 2 C 3 ILE A 160 GLU A 166 -1 N GLU A 166 O ASN A 118 SHEET 3 C 3 VAL A 174 GLU A 179 -1 N TRP A 178 O TYR A 161 SHEET 1 D 4 HIS B 9 THR B 18 0 SHEET 2 D 4 ARG B 23 TYR B 32 -1 N ILE B 31 O GLN B 10 SHEET 3 D 4 GLU B 35 ASP B 41 -1 N PHE B 40 O ILE B 28 SHEET 4 D 4 TYR B 47 ALA B 49 -1 N ARG B 48 O ARG B 39 SHEET 1 E 4 SER B 98 LEU B 103 0 SHEET 2 E 4 HIS B 112 PHE B 122 -1 N THR B 120 O SER B 98 SHEET 3 E 4 PHE B 155 THR B 164 -1 N MET B 163 O ASN B 113 SHEET 4 E 4 VAL B 142 SER B 144 -1 N SER B 143 O MET B 160 SHEET 1 F 4 GLN B 136 GLU B 138 0 SHEET 2 F 4 LYS B 128 ARG B 133 -1 N ARG B 133 O GLN B 136 SHEET 3 F 4 VAL B 170 GLU B 176 -1 N GLU B 176 O LYS B 128 SHEET 4 F 4 ILE B 184 ARG B 189 -1 N TRP B 188 O TYR B 171 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.04 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.06 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.02 LINK ND2 ASN A 78 C1 NAG A 196 1555 1555 1.46 LINK ND2 ASN A 118 C1 NAG A 197 1555 1555 1.45 LINK C1 NAG B 3 ND2 ASN B 19 1555 1555 1.46 CISPEP 1 SER A 15 PRO A 16 0 0.16 CISPEP 2 PHE A 113 PRO A 114 0 -0.21 CISPEP 3 TYR B 123 PRO B 124 0 0.04 CRYST1 112.250 112.250 99.720 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008909 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008909 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010028 0.00000